Tags: MDMAecstasyPTSD therapypsychotherapyremission
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 2 | Nicoletta Lanese Live Science Science journalist. New York, USA | ||
| 3 | Michael DePeau-Wilson MedPage Today Enterprise Reporter. AI in Healthcare focus. Journalism alum. Not specified | PTSD Ran High Among Physicians During COVID-19 Pandemic - 7 months ago At-Home Electrical Stimulation Fails to Treat Major Depressive Episodes - about 1 year ago Guidance Focuses on Mental Health Symptoms in Long COVID - over 1 year ago | |
| 4 | Randy Dotinga MedPage Today Indie scribbler, advocate.
Board member, @ahcj. San Diego | ||
| 5 | Marissa Plescia MedCity News Reporter at MedCity News. | What’s Next for Psychedelic Medicines? - 4 months ago | |
| 6 | Derek Harrison InsideClimate News Art and production director. Portland, Oregon | ||
| 7 | David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK | ||
| 8 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 6 months ago A tough week for MDMA-assisted psychotherapy - 6 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 7 months ago | |
| 9 | Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. | ||
| 10 | Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania | The FDA Just Rejected a Bid for MDMA to Treat PTSD - 7 months ago The Case for MDMA’s Approval Is Riddled With Problems - 9 months ago They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better - about 1 year ago |